TIM-3 therapy for Alzheimer's has emerged as a promising avenue in the fight against this devastating disease.Recent studies reveal that by targeting the TIM-3 checkpoint molecule, which is known to inhibit the immune function of microglia in the brain, there may be potential to improve cognitive abilities in Alzheimer's patients.